ICNDT · Registering as Listener

International Conference on Neonatal Diabetes and Treatments

📅 22–23 Apr 2027 📍 Al Khobar, Saudi Arabia 👤 Standard / Listener

Listener registration from

$185

virtual · $185 in person

Registration benefits
✉
Official invitation letterIssued automatically after registration
📜
Certificate & digital materialsCertificate, slides and resource materials
🌐
Supporting global researchConnect with researchers across 30+ countries

For Support Please Contact

[email protected]

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessionsNetworkingCertificateInvitation letterConference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

Coupon code

Have a code? Apply it here — the discount updates the total immediately.

Apply

I agree to the Terms & Conditions and Refund & Cancellation Policy.

VISAMastercardAmexPayPal

Payments encrypted & processed securely. Refundable up to 14 days before the event.

Conference session tracks

Key research areas covered across the sessions — tap a track to read more.

This track will explore the intricate functions of alpha and beta cells within the endocrine pancreas. Emphasis will be placed on their roles in insulin secretion and glucose homeostasis.

This session will delve into the underlying mechanisms that differentiate Type 1 and Type 2 diabetes. Discussions will include immune responses, genetic factors, and metabolic dysregulation.

This track will focus on the global prevalence and risk factors associated with diabetes. It will also cover the pathophysiological processes that contribute to the onset of the disease.

This session will investigate the relationship between diabetes and metabolic syndrome, highlighting shared risk factors and therapeutic approaches. The implications for public health and clinical practice will also be discussed.

This track will address the various complications arising from diabetes, including cardiovascular, renal, and neurological issues. Innovative management strategies and treatment modalities will be presented.

This session will cover the latest research in the genetic underpinnings of diabetes. Participants will explore how genetic discoveries are shaping personalized medicine approaches.

This track will focus on the unique aspects of diabetes in neonates and children, including diagnosis and management challenges. Innovative treatment options and research advancements will be highlighted.

This session will explore the role of incretin hormones in the regulation of insulin secretion. The potential therapeutic implications of incretin-based therapies will also be discussed.

This track will showcase cutting-edge technologies aimed at improving diabetes management, including continuous glucose monitoring and insulin delivery systems. The impact of digital health on patient outcomes will be examined.

This session will address the regulatory challenges and economic considerations in diabetes research and treatment. Discussions will focus on policy implications and funding opportunities.

This track will highlight the use of computational methods in understanding diabetes pathophysiology and treatment outcomes. Participants will explore data analytics, modeling, and bioinformatics applications.